Shankar Musunuri
Chief Executive Officer bei OCUGEN, INC.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Shankar Musunuri is the founder.
He founded Nuron Biotech, Inc. in 2009 and served as the President, Chief Executive Officer & Director in 2013.
He also founded Ocugen, Inc. in 2013 and holds the position of Chairman & Chief Executive Officer.
Additionally, Dr. Musunuri founded Ocugen OpCo, Inc. in 2013 and serves as the Executive Chairman & Chief Executive Officer starting from 2015.
In his former positions, Dr. Musunuri worked at Pfizer Inc. from 1996 to 2010, where he held the role of Senior Director-Global Technology Transfer.
He also worked at Wyeth LLC as a Principal.
Prior to that, he worked at Amylin Pharmaceuticals, Inc. from 1993 to 1996 as a Principal.
Dr. Musunuri obtained a doctorate degree from the University of Connecticut and an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OCUGEN INC
1,23% | 03.01.2024 | 3 155 168 ( 1,23% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Shankar Musunuri
| Unternehmen | Position | Beginn |
|---|---|---|
| OCUGEN, INC. | Chief Executive Officer | 27.09.2019 |
| Ocugen OpCo, Inc. | Chief Executive Officer | 01.05.2015 |
Ehemalige bekannte Positionen von Shankar Musunuri
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.1996 |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Chief Executive Officer | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Founder | - |
Ausbildung von Shankar Musunuri
| University of Connecticut | Doctorate Degree |
| The Fuqua School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Health Technology |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
